• Northumbria University Featured PhD Programmes
  • University of Glasgow Featured PhD Programmes
  • University of Bristol Featured PhD Programmes
  • Medical Research Council, Harwell Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • National University of Singapore Featured PhD Programmes
  • University of East Anglia Featured PhD Programmes

Postgrad LIVE! Study Fair

Birmingham | Bristol | Sheffield | Liverpool | Edinburgh

University of Birmingham Featured PhD Programmes
University of Southampton Featured PhD Programmes
Manchester Metropolitan University Featured PhD Programmes
University of Glasgow Featured PhD Programmes
University of Manchester Featured PhD Programmes

Molecular basis of pathogenesis: Structure based design of novel therapeutics for the treatment of infectious diseases

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Prof R L Brady
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

About This PhD Project

Project Description

Through the study of protein structure, primarily using protein crystallography but also electron microscopy and small-angle X-ray scattering, we aim to probe crucial biomolecular interactions central to a variety of diseases. The aim is to use this information to accelerate the development of new drugs and therapeutics.

Studies within the group focus on a variety of proteins from human and animal specific pathogens including bacterial adhesin molecules and potential drug target from trypanosomes. We also have an interest in both the design of novel proteins and artificial genomic systems. We employ a wide range of techniques from recombinant DNA technology, protein purification and characterisation, proteomics approaches through to structure determination using crystallography and molecular modelling. We adopt an interdisciplinary approach to the discovery of new therapeutics, frequently requiring working close to the industrial and academic medical biochemistry interface.

Webpage Link: http://www.bris.ac.uk/biochemistry/brady/

References

Antony J. Burton, Andrew R. Thomson, William M. Dawson, R. Leo Brady & Derek N. Woolfson (2016) ‘Installing hydrolytic activity into a completely de novo protein framework‘ Nature Chemistry DOI:10.1038/nchem.2555

Thomson, A. R., Wood, C. W., Burton, A. J., Bartlett, G. J., Sessions, R. B., Brady, R. L. & Woolfson, D. N. (2014) ‘Computational design of water-soluble α-helical barrels’ Science 346 (6208), 485-488

Zaccai NR, Chi B, Thomson AR, Boyle AL, Bartlett GJ, Bruning M, Linden N, Sessions RB, Booth PJ, Brady RL & Woolfson DN (2011) A de novopeptide hexamer with a mutable channel. Nature Chem Biol 7, 935-941

Agnew C, Borodina E, Zaccai NR, Conners R, Burton NM, Vicary JA, Cole DK, Antognozzi M, Virji M, & Brady RL (2011) Correlation of in situ mechanosensitive responses of the Moraxella catarrhalis adhesin UspA1 with fibronectin and receptor CEACAM1 binding. PNAS 108 (37), 15174-15178

Related Subjects

Meet University of Bristol at

Postgrad LIVE! BIRMINGHAM
Postgrad LIVE! BRISTOL
Postgrad LIVE! SHEFFIELD
Postgrad LIVE! LIVERPOOL
Postgrad LIVE! EDINBURGH

Cookie Policy    X